<DOC>
	<DOCNO>NCT02026505</DOCNO>
	<brief_summary>The purpose study learn drug commonly use treat multiple myeloma affect heart . In study , investigator learn whether drug call drug ( call bortezomib , Velcade ) receive multiple myeloma affect heart . Bortezomib part standard treatment effect multiple myeloma study . The investigator want learn whether damage occur heart take bortezomib multiple myeloma , whether reversible , predict damage heart occur .</brief_summary>
	<brief_title>Evaluation Cardiotoxic Effects Bortezomib</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Proteasome Inhibitors</mesh_term>
	<criteria>diagnosis multiple myeloma treatment plan involve great 4 cycle bortezomibbased chemotherapy preexist history leave ventricular systolic dysfunction congestive heart failure coronary artery disease significant valvular heart disease cardiac arrhythmia estimate glomerular filtration rate &lt; 30 mL/min/1.73m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>